-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK & CO - TWO ADDITIONAL PHASE 3 TRIALS UNDERWAY FOR IFINATAMAB DERUXTECAN IN CRPC AND ESCC

Reuters·09/25/2026 20:30:22

Please log in to view news